Literature DB >> 30501405

Measurement Invariance of the WHODAS 2.0 Across Youth With and Without Physical or Mental Conditions.

Braden K Tompke1, Jennie Tang1, Irina I Oltean1, M Claire Buchan1, Shannon V Reaume1, Mark A Ferro1.   

Abstract

Initial evidence suggests that the WHO Disability Assessment Schedule (WHODAS 2.0) is valid and reliable in general youth populations; however, its psychometric properties in specific subgroups are less established. The primary objective was to test for measurement invariance of the 12-item WHODAS 2.0 in an epidemiological sample of youth aged 15 to 19 years with and without physical or mental conditions. Using data from 1,851 youth in the Canadian Community Health Survey-Mental Health, invariance was tested using multiple-group confirmatory factor analysis. Within-domain item correlations were significant and ordinal coefficient alphas were .91, .94, .93, and .92 for the healthy control, physical, mental, and comorbid groups, respectively. Partial measurement invariance was demonstrated for the WHODAS 2.0, with evidence of noninvariance for item residuals and factor variances related to cognition and participation. While these domain-specific comparisons may be biased, valid comparisons of overall disability across subgroups of youth can be made with confidence.

Entities:  

Keywords:  adolescents; chronic disease; disability; measurement; mental disorder; validity; young adults

Mesh:

Year:  2018        PMID: 30501405     DOI: 10.1177/1073191118816435

Source DB:  PubMed          Journal:  Assessment        ISSN: 1073-1911


  9 in total

1.  Measuring health-related quality of life in young children with physical illness: psychometric properties of the parent-reported KIDSCREEN-27.

Authors:  Mark A Ferro; Christiane Otto; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2021-12-02       Impact factor: 4.147

2.  Parent-Child Agreement on the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID).

Authors:  Erica McDonald; Sydney Whitney; Laurie Horricks; Ellen L Lipman; Mark A Ferro
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-11-01

3.  Health-related quality of life in children with and without physical-mental multimorbidity.

Authors:  Mark A Ferro; Saad A Qureshi; Lilly Shanahan; Christiane Otto; Ulrike Ravens-Sieberer
Journal:  Qual Life Res       Date:  2021-07-31       Impact factor: 4.147

4.  Cohort Profile: Multimorbidity in Children and Youth Across the Life-course (MY LIFE) Study.

Authors:  Mark A Ferro; Ellen L Lipman; Ryan J Van Lieshout; Brian Timmons; Lilly Shanahan; Jan Willem Gorter; Kathy Georgiades; Michael Boyle
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-05-01

5.  Measurement Invariance of the GAD-7 and CESD-R-10 Among Adolescents in Canada.

Authors:  Isabella Romano; Mark A Ferro; Karen A Patte; Scott T Leatherdale
Journal:  J Pediatr Psychol       Date:  2022-05-13

6.  Multimorbidity in Children and Youth Across the Life-course (MY LIFE): protocol of a Canadian prospective study.

Authors:  Mark A Ferro; Ellen L Lipman; Ryan J Van Lieshout; Jan Willem Gorter; Lilly Shanahan; Michael Boyle; Kathy Georgiades; Brian Timmons
Journal:  BMJ Open       Date:  2019-11-03       Impact factor: 2.692

7.  Correlates of Moderate-to-Vigorous Physical Activity in Children With Physical Illness and Physical-Mental Multimorbidity.

Authors:  Chloe Bedard; Sara King-Dowling; Joyce Obeid; Brian W Timmons; Mark A Ferro
Journal:  Health Educ Behav       Date:  2022-06-13

8.  Measurement Invariance of the Flourishing Scale among a Large Sample of Canadian Adolescents.

Authors:  Isabella Romano; Mark A Ferro; Karen A Patte; Ed Diener; Scott T Leatherdale
Journal:  Int J Environ Res Public Health       Date:  2020-10-25       Impact factor: 3.390

9.  Prevalence and Correlates of Physical-mental Multimorbidity in Outpatient Children From a Pediatric Hospital in Canada.

Authors:  Mark A Ferro; Saad Qureshi; Ryan J Van Lieshout; Ellen L Lipman; Kathy Georgiades; Jan Willem Gorter; Brian W Timmons; Lilly Shanahan
Journal:  Can J Psychiatry       Date:  2022-01-21       Impact factor: 5.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.